Eleison Pharmaceuticals Inc. (ELSN)
Eleison Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jun 29, 2023.
Stock Price: Pending
IPO price not available yet

Eleison Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20202019
Cash & Equivalents
4.870.05
Cash & Cash Equivalents
4.870.05
Cash Growth
8838.00%-
Receivables
1-
Other Current Assets
0.010.01
Total Current Assets
5.870.06
Other Long-Term Assets
00
Total Long-Term Assets
00
Total Assets
5.870.06
Deferred Revenue
-0.07
Current Debt
0.044.57
Other Current Liabilities
3.578.76
Total Current Liabilities
3.6213.4
Long-Term Debt
0.5-
Total Long-Term Liabilities
0.50
Total Liabilities
4.1213.4
Total Debt
0.544.57
Debt Growth
-88.10%-
Retained Earnings
-25.5-19.76
Shareholders' Equity
1.76-13.34
Net Cash / Debt
4.32-4.51
Working Capital
2.26-13.34
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).